[Profound mycoses in AIDS in Abidjan (Côte d'Ivoire)].
During 1995, among 1105 HIV patients explored in our department, 64 presented a deep fungic infection (5.8%). The yeast was searched for in cerebrospinal fluid, blood, urine, and bronchoalveolar aspiration. Isolated germs were Cryptococcus neoformans (95%), Candida tropicalis (1 case), Saccharomyces cerevisiae (1 case) et Aspergillus fumigatus (1 case). Results of treatment with amphotericin B were: recovery (9%), clinical success (11%), out of sight (14%), letality (66%), relapse (23%) and side effects (19%). We emphasized diagnostical and therapeutical difficulties, and bad prognostic of mycoses in patients with AIDS.
Eholie
S P
SP
Service de maladies infectieuses et tropicales, CHU de Treichville, Abidjan, Côte d'Ivoire.
N'gbocho
L
L
Bissagnene
E
E
Coulibaly
M
M
Ehui
E
E
Kra
O
O
Assoumou
A
A
Aoussi
E
E
Kadio
A
A
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D001826:Body Fluids / Q000382:microbiology; D002175:Candida / Q000302:isolation & purification; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D007560:Cote d'Ivoire; D003453:Cryptococcosis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D003455:Cryptococcus neoformans / Q000302:isolation & purification; D006801:Humans; D009181:Mycoses / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D011379:Prognosis; D012441:Saccharomyces cerevisiae / Q000302:isolation & purification
D000935:Antifungal Agents; D000666:Amphotericin B
Mycoses profondes au cours du SIDA à Abidjan (Côte d'Ivoire).